Top Featured Companies Dominating the Global Gastrointestinal Radiofrequency Ablation Systems Market
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ATRICURE, INC.
- Royal Philips
- Boston Scientific Corporation
- Johnson & Johnson
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of gastrointestinal radiofrequency ablation systems is assessed at USD 4.54 billion.
The gastrointestinal radiofrequency ablation systems market size was valued at USD 4.28 billion in 2024 and is expected to reach USD 10.44 billion by 2037, registering around 7.1% CAGR during the forecast period i.e., between 2025-2037. Growing preference for minimally invasive procedures and growing prevalence of gastrointestinal diseases will drive the market growth.
North America industry is likely to dominate majority revenue share of 35% by 2037, attributed to increasing incidence of stomach cancer in the region.
The major players in the market are ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc. and others
